MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/dmso.s650265

Медицинская библиотека · Diabetes, metabolic syndrome and obesity : targets and therapy · 2026

Diabetes Mellitus in Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Prevalence of Types and Risk Factors.

Kake Kimia, Jalilian Milad

СтатьяОбзорПеревод пока не подготовлен

Аннотация

BACKGROUND

Schizophrenia is associated with an increased risk of diabetes mellitus (DM) and type 2 diabetes mellitus (T2DM), yet the overall burden and related risk factors remain incompletely characterized.

AIM: This study aimed to estimate the prevalence of DM in overall and T2DM in patients with schizophrenia and to summarize associated risk factors.

METHODS

This PRISMA-guided systematic review and meta-analysis included observational studies reporting DM or T2DM in patients with schizophrenia. Databases were systematically searched. Pooled prevalence estimates were calculated using a random-effects model in CMA software. Heterogeneity was assessed using Cochran's Q test and I2, while publication bias was evaluated using Egger's regression test and trim-and-fill analysis.

RESULTS

Thirty-five studies involving 139,304 individuals were included, and 34 studies contributed to the meta-analysis. The pooled prevalence of DM was 10.4% (95% CI: 8.3-12.9%), and the pooled prevalence of T2DM was 13.2% (95% CI: 9.1-18.9%). Between-study heterogeneity was substantial for both outcomes (I2 = 99.49% and 99.38%, respectively). Egger's test suggested possible publication bias; however, trim-and-fill analysis identified no missing studies and did not alter the pooled estimates. Commonly reported risk factors included older age, female sex, obesity or higher body mass index, family history of diabetes, sedentary lifestyle, lower socioeconomic status, longer illness duration, and antipsychotic exposure, particularly clozapine and olanzapine.

CONCLUSION

Overall diabetes, particularly type 2 diabetes, is prevalent among patients with schizophrenia and associated with demographic, clinical, treatment-related, and medication-related risk factors. These findings support routine metabolic screening and early preventive interventions to reduce diabetes risk and improve health outcomes in this high-risk population.

Для цитирования: Kake Kimia, Jalilian Milad. Diabetes Mellitus in Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Prevalence of Types and Risk Factors.. Diabetes, metabolic syndrome and obesity : targets and therapy. 2026. DOI: 10.2147/dmso.s650265.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.